Eli Lilly’s Alzheimer’s Drug Shows Promise in Small Trial January 11, 2021 Auto Bot alzheimer's disease, Clinical Trials, donanemab, Eli Lilly and Company, Research 0 Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say.